United States: First Circuit Affirms Dismissal Of FCA Whistleblower Suit Against Takeda Pharmaceuticals

The First Circuit recently affirmed the dismissal of U.S. ex rel. Ge v. Takeda Pharmaceuticals, a whistleblower suit alleging that defendant's failure to disclose certain risks relating to four drugs and to report adverse events under the Food & Drug Administration's regulations resulted in False Claims Act ("FCA") violations. The court affirmed the district court's dismissal for failure to plead with sufficient particularity under Federal Rule of Civil Procedure 9(b). The court held without reservation that Rule 9(b) requires relators to plead with specificity that false claims were actually submitted, and that pleading circumstances that allegedly give rise to the inference that false claims were filed is not enough. The court declined to address substantively or to rule on the district court's second basis for dismissal: failure to state a claim under Rule 12(b)(6). A copy of the court's decision can be found here.

Procedural History

Relator, Dr. Helen Ge, worked as a contractor for defendant Takeda, performing medical review of adverse event reports for four drugs. This appeal resulted from the dismissal of two consolidated complaints alleging that Takeda violated adverse event reporting requirements by instructing doctors to modify their findings and by failing to make public information about adverse side effects of the drugs. The district court dismissed both complaints for failure to plead fraud with particularity under Federal Rule of Civil Procedure 9(b) and for failure to state a claim under Rule 12(b)(6).

On appeal, relator challenged both of the district court's holdings with respect to FCA liability. First, she argued dismissal under Rule 9(b) was inappropriate because a qui tam relator alleging that a defendant caused a third party to submit a false claim need only provide factual or statistical evidence to strengthen the inference of fraud; she argued a relator need not provide detail as to the false claims that were allegedly submitted. Relator argued that she met this standard by providing aggregate expenditure data in her motion for reconsideration before the district court. Second, relator maintained that the district court erred in dismissing her claims under Rule 12(b)(6) because it improperly narrowed the FCA's materiality standard. The district court held that defendant's violations could not be material because the FDA had the discretion—but, critically, not the obligation—to remove drugs from the market for violations of reporting requirements.

The First Circuit Affirmed on Rule 9(b) Grounds

In affirming the dismissal under Rule 9(b), the Court found that relator's twice-amended complaints failed to satisfy the heightened pleading standards for fraud. Rule 9(b) requires relators to state with particularity the "who, what, when, where, and how" of the alleged FCA violation. The court highlighted relator's failure to allege facts showing that any false claims were actually submitted as a result of defendant's alleged regulatory violations. The court flatly rejected relator's proposed per se rule that if sufficient allegations of misconduct are pled, it must follow that false claims were submitted. As the court noted, "[w]hat is missing are any supporting allegations upon which her conclusion rests and any particulars." Relator made no attempt to identify some subset of claims submitted for government payment which were false, and the court was even less convinced that all claims submitted for these four drugs during the relevant time period were false. Though relator attempted to add aggregate expenditure data and declarations from patients in her motion for reconsideration, the court found that the additional facts were added too late and, in any event, were still insufficient to satisfy Rule 9(b).

Relator attempted to allege three new theories on appeal, which the court deemed waived as a result of her failure to introduce the arguments at the district court level. Notably, the court expressed doubt that such theories would have survived the Rule 9(b) analysis, citing with approval the Fourth Circuit's Rule 9(b) analysis in United States ex rel. Nathan v. Takeda Pharm. N. Am., Inc.1

The Government's Amicus Position and Future Implications of Ge

Though the government did not intervene in relator's FCA complaints, the U.S. Department of Justice filed an amicus curiae brief during the course of this appeal, challenging the district court's legal grounds for the Rule 12(b)(6) dismissal. First, the government addressed its view of the materiality standard for false statements regarding compliance with rules and regulations that are a precondition to payment. It stated that a false statement or omission (like failing to report adverse effects of a drug to the FDA) is material if, in light of the statement, the agency was permitted to deny payment, regardless of whether it actually did so or was required to deny payment. Second, the government asserted that the availability of alternative administrative remedies does not preclude FCA claims. Rather, the government argued, the FCA allows for multiple enforcement mechanisms that both the government and whistleblowers may use. Third, the government argued against a per se rule barring FCA liability for failure to comply with FDA adverse event reporting requirements, though it conceded that liability in such circumstances would be rare.

By affirming the district court on Rule 9(b) grounds alone, the First Circuit left these critical issues regarding the use of the FCA to police regulatory compliance for another day. It also left intact the line of district court cases that have held that violations of adverse event reporting requirements are not automatically grounds for FCA liability. We will continue to monitor developments in this evolving area of FCA jurisprudence. If you have further questions about the implications of the Ge decision, please consult your usual Ropes & Gray advisor or an attorney in our False Claims Act practice.


[1] The relator-appellant in Nathan has filed a pending petition for certiorari with the United States Supreme Court to appeal the Fourth Circuit's ruling requiring relators to "allege with particularity that specific false claims actually were presented to the government for payment" where a defendant's actions "could have led, but need not necessarily have led, to the submission of false claims."

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

*** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.